Loading…
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
5-year financial trends. Figures in USD millions.
Latest fiscal year: 2025
Year-by-year revenue, profitability, and cash flow (USD millions, last 10 years)
| Year | Revenue | EBITDA | Net Profit | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|
| 2025 | $15.1B | $3.0B | $1.5B | $1.7B | 13.7% | -2.1% | 42.7% |
| 2024 | $15.5B | $2.5B | $1.0B | $1.3B | 10.7% | 0.1% | -38.1% |
| 2023 | $15.4B | $3.2B | $1.7B | $2.7B | 14.8% | 3.3% | -19.4% |
| 2022 | $14.9B | $3.3B | $2.1B | $2.1B | 10.3% | - | - |
| 2021 | - | - | - |
Income statement, balance sheet, and cash flow as reported
Consolidated Figures in USD Millions.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Revenue | - | 14,950 | 15,444 | 15,455 | 15,124 |
| Cost Of Revenue | - | 6,665 | 6,801 | 6,496 | 6,332 |
| Gross Profit | - | 8,285 | 8,643 | 8,959 | 8,792 |
| Operating Expense | - | 5,597 | 6,150 | 6,330 | 6,077 |
| Operating Income | - | 2,688 | 2,493 | 2,629 | 2,715 |
| EBITDA | - | 3,281 | 3,175 | 2,468 | 2,986 |
| EBIT | - | 2,637 | 2,548 | 1,846 | 2,429 |
| Pretax Income | - | 2,637 | 2,190 | 1,415 | 1,999 |
| Tax Provision | - | 573 | 526 | 385 | 529 |
| Net Income | - | 2,064 | 1,664 | 1,030 | 1,470 |
| Net Income Common Stockholders | - | 2,064 | 1,664 | 1,030 | 1,470 |
| Total Expenses | - | 12,262 | 12,951 | 12,826 | 12,409 |
| Interest Expense | - | 0 | 358 | 431 | 430 |
| Interest Income | - | 0 | 108 | 53 | 51 |
| Selling General And Administration | - | 5,633 | 6,141 | 6,329 | 6,088 |
| Normalized EBITDA | - | 3,335 | 3,221 | 3,308 | 3,333 |
| Normalized Income | - | 2,106.28 | 1,698.96 | 1,641.45 | 1,725.17 |
| Market Cap | 33,579.34 | 33,579.34 | 33,579.34 | 33,579.34 | 33,579.34 |
Consumer Defensive sector peers, ranked by market cap
| Company | Ticker | Market Cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|---|
| Kenvue Inc.this co. | KVUE | $33.8B | 22.84↓ discount | 3.12 | 13.7% | 13.79 |
| Coca-Cola Europacific Partners PLC | CCEP | $44.7B | 22.49 | 5.57 | 24.8% | 14.19 |
| The Kroger Co. | KR | $44.1B | 41.88 | 7.18 | 17.1% | 11.10 |
| The Hershey Company | HSY | $37.9B | 43.94 | 8.37 | 19.0% | 22.46 |
| Sysco Corporation | SYY | $37.4B | 20.06 |
| - |
| - |
| - |
| - |
| 20.04 |
| 99.9% |
| 12.11 |
| Archer-Daniels-Midland Company | ADM | $33.2B | 30.95 | 1.47 | 4.7% | 13.81 |
| Kimberly-Clark Corporation | KMB | $32.5B | 16.07 | 21.62 | 134.6% | 12.56 |
| Church & Dwight Co., Inc. | CHD | $23.0B | 30.55 | 5.62 | 18.4% | 18.70 |
| Tyson Foods, Inc. | TSN | $22.1B | 47.56 | 1.25 | 2.6% | 11.69 |
| Peer Median | - | 30.75 | 6.40 | 18.7% | 13.18 | |